News from allon therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 10, 2013, 16:29 ET

Allon Receives Court Approval for Proposal and Reorganization

VANCOUVER, July 10, 2013 /CNW/ - Allon Therapeutics Inc. (TSX: NPC) ("Allon" or the "Company") refers to its news release dated May 30, 2013...

Jun 07, 2013, 13:30 ET

Allon Provides Update to its Proposal and Reorganization

VANCOUVER, June 7, 2013 /CNW/ - Allon Therapeutics Inc. (TSX: NPC) ("Allon" or the "Company") refers to its news release dated May 30, 2013...

May 30, 2013, 09:00 ET

Allon Announces the Filing of a Proposal with Creditors and Reorganization

VANCOUVER, May 30, 2013 /CNW/ - Allon Therapeutics Inc. (TSX: NPC) ("Allon" or the "Company") announced today that it has filed a proposal (the...

Dec 18, 2012, 13:48 ET

Allon announces PSP clinical trial results

VANCOUVER, Dec. 18, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that its pivotal clinical trial evaluating its lead...

Dec 05, 2012, 08:30 ET

The United States, New Zealand & Mexico Issue Patent for New Allon Platform

VANCOUVER, Dec. 5, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that the United States, New Zealand and Mexican patent...

Nov 29, 2012, 08:30 ET

Allon selected as Top 10 partnering prospect by CNS experts

VANCOUVER, Nov. 29, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) was selected as one of the "Top 10 CNS Licensing Prospects" and will...

Nov 22, 2012, 14:08 ET

Allon files preliminary shelf prospectus

VANCOUVER, Nov. 22, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) has filed a preliminary short form base shelf prospectus (the "Shelf...

Nov 13, 2012, 08:30 ET

Patient treatment completed in pivotal trial evaluating Allon's davunetide

VANCOUVER, Nov. 13, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that patient treatment has been completed in the...

Nov 05, 2012, 19:30 ET

Allon Therapeutics releases Q3 operating results and provides corporate update

VANCOUVER, Nov. 5, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) today announced its unaudited operating results for the three and...

Oct 10, 2012, 08:30 ET

Allon's CEO presenting at 2012 BIO Investor Forum and Updating Guidance

VANCOUVER, Oct. 10, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley will present an update of the...

Sep 11, 2012, 08:30 ET

Allon's CEO presenting at 2012 Rodman and Renshaw Global Conference

VANCOUVER, Sept. 11, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley will present an update of the...

Aug 07, 2012, 17:00 ET

Allon Therapeutics releases Q2 operating results and provides corporate update

VANCOUVER, Aug. 7, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) today announced its unaudited operating results for the three and...

Jul 16, 2012, 08:30 ET

Allon Presents Baseline Data from PSP Clinical Trial to Alzheimer's Conference

VANCOUVER, July 16, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced that data presented at the Alzheimer's Association...

Jun 21, 2012, 08:30 ET

Allon CEO updates Bloom Burton & Co. Healthcare Investor Conference

VANCOUVER, June 21, 2012 /PRNewswire/ - Allon Therapeutics Inc. TSX: NPC President and CEO Gordon McCauley is presenting an update of the Company's...

Jun 14, 2012, 08:30 ET

Allon Therapeutics shareholders approve $10-million private placement

VANCOUVER, June 14, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) said today that its shareholders have approved the terms of the $10...

May 30, 2012, 08:30 ET

Allon CEO updates BioFinance Conference on pivotal trial progress and DSMB recommendation

VANCOUVER, May 30, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) President and CEO Gordon McCauley is presenting an update of the...

May 14, 2012, 08:30 ET

New Allon research presented at leading scientific symposium

VANCOUVER, May 14, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that a presentation given May 12 at the prestigious 12th...

May 02, 2012, 08:00 ET

Allon Therapeutics announces completion of $10 million private placement

VANCOUVER, May 2, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that it has completed the previously announced brokered...

Apr 16, 2012, 08:00 ET

Allon Therapeutics announces private placement

VANCOUVER, April 16, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that  it plans to complete a brokered private...

Mar 28, 2012, 08:30 ET

Allon granted U.S. patent for neurotoxicity caused by anti-cancer drugs

VANCOUVER, March 28, 2012 /PRNewswire/ - Allon Therapeutics Inc. (TSX: NPC) announced today that it has been granted a U.S. patent that covers the...